COV.AX ASX
Cleo Diagnostics Ltd
1W: +16.9%
YTD: -1.4%
A$0.34 ($0.24)
+0.03 (+7.81%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapA$49.1M ($34.1M)
52W Range0.27-0.9
Volume202,365
Avg Volume147,576
Beta0.36
Dividend—
Analyst Ratings
No analyst coverage
Company Info
480 Collins Street
Melbourne, VIC 3000
AU
Melbourne, VIC 3000
AU
About Cleo Diagnostics Ltd
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Latest News
No recent news
Recent Insider Trades
No insider trades found